Encompass Health Co. (NYSE:EHC) Shares Sold by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its stake in Encompass Health Co. (NYSE:EHC) by 61.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,525 shares of the company’s stock after selling 5,703 shares during the period. GSA Capital Partners LLP’s holdings in Encompass Health were worth $341,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in EHC. Los Angeles Capital Management LLC increased its position in shares of Encompass Health by 532.4% during the third quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock worth $4,860,000 after purchasing an additional 42,338 shares in the last quarter. Crossmark Global Holdings Inc. grew its stake in Encompass Health by 8.3% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 7,952 shares of the company’s stock worth $769,000 after buying an additional 612 shares during the last quarter. Verdence Capital Advisors LLC increased its position in Encompass Health by 4.6% during the third quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after buying an additional 160 shares during the period. QRG Capital Management Inc. lifted its stake in Encompass Health by 9.1% in the third quarter. QRG Capital Management Inc. now owns 15,672 shares of the company’s stock valued at $1,515,000 after buying an additional 1,307 shares during the last quarter. Finally, Harbor Capital Advisors Inc. boosted its holdings in shares of Encompass Health by 104.7% in the third quarter. Harbor Capital Advisors Inc. now owns 73,272 shares of the company’s stock valued at $7,081,000 after acquiring an additional 37,473 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on EHC. Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 30th. UBS Group increased their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Truist Financial restated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp increased their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Finally, Stephens restated an “overweight” rating and set a $105.00 price target on shares of Encompass Health in a research note on Tuesday, August 6th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Trading Up 1.8 %

Shares of NYSE EHC opened at $101.14 on Friday. The stock’s 50 day moving average price is $97.11 and its two-hundred day moving average price is $90.81. Encompass Health Co. has a 52-week low of $63.78 and a 52-week high of $104.55. The stock has a market capitalization of $10.19 billion, a P/E ratio of 24.43, a PEG ratio of 1.31 and a beta of 0.88. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last posted its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period last year, the business posted $0.86 earnings per share. On average, analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.